Imagion Biosystems Limited has released “Form 604: Notice of change of interests of substantial holder” to the market.
Read Form 604.
Form 604: Notice of change of interests of substantial holder
Highlights: Announced preliminary performance of MagSense® HER2 Imaging Agent in phase 1 study after study closure (post quarter end) Entered a strategic partnership with Prestige
Transforming medical imaging for early disease detection
We’re on a mission to make cancer more detectable.